Nothing Special   »   [go: up one dir, main page]

Hamari et al., 2016 - Google Patents

Analyses of regulatory CD 4+ CD 25+ FOXP 3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in …

Hamari et al., 2016

View PDF @Full View
Document ID
13977454765466008848
Author
Hamari S
Kirveskoski T
Glumoff V
Kulmala P
Simell O
Knip M
Veijola R
Publication year
Publication venue
Scandinavian journal of immunology

External Links

Snippet

Our aim was to study whether the aberrant amount or function of regulatory T cells is related to the development of type 1 diabetes (T1D) in children. We also set out to investigate the balance of different T cell subtype markers during the T1D autoimmune process. Treg cells …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Hamari et al. Analyses of regulatory CD 4+ CD 25+ FOXP 3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children
Viisanen et al. FOXP3+ regulatory T cell compartment is altered in children with newly diagnosed type 1 diabetes but not in autoantibody-positive at-risk children
Abraham et al. Flow cytometry, a versatile tool for diagnosis and monitoring of primary immunodeficiencies
Beers et al. ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity
Kitz et al. Regulatory T cells: from discovery to autoimmunity
Piątosa et al. B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood
Zhang et al. Clinical significance of increased CD4+ CD25− Foxp3+ T cells in patients with new-onset systemic lupus erythematosus
Ahmed et al. Standardizing T-cell biomarkers in type 1 diabetes: challenges and recent advances
Feger et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation
Martino et al. Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans
Lawson et al. Increased resistance to CD4+ CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes
Orsini et al. Enumeration of human peripheral blood dendritic cells throughout the life
Miyara et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor
Fessler et al. Novel senescent regulatory T-cell subset with impaired suppressive function in rheumatoid arthritis
Yang et al. Natural variation in interleukin-2 sensitivity influences regulatory T-cell frequency and function in individuals with long-standing type 1 diabetes
Thompson et al. Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes
Oras et al. A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients
Nunes‐Cabaço et al. Differentiation of human thymic regulatory T cells at the double positive stage
Mohme et al. HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis
Zóka et al. Extension of the CD4+ Foxp3+ CD25−/low regulatory T-cell subpopulation in type 1 diabetes mellitus
Yuan et al. Phenotypical changes and clinical significance of CD4+/CD8+ T cells in SLE
Hu et al. Analysis of regulatory T cell subsets and their expression of Helios and PD‐1 in patients with Hashimoto thyroiditis
Heninger et al. Activation of islet autoreactive naive T cells in infants is influenced by homeostatic mechanisms and antigen-presenting capacity
Tan et al. Increased circulating CXCR 5+ CD 4+ T follicular helper‐like cells in oral lichen planus
Aghili et al. Altered suppressor function of regulatory T cells in type 1 diabetes